Merck, Schering-Plough results get boost from cholesterol drugs

Article Abstract:

Merck and Company Inc. of the United States net profit soared in the second quarter and financial projections for the year were raised. Revenues were buoyed by increased sales of cholesterol drugs. Financial projections may be affected by generic knock offs of the cholesterol drug Zocor.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

Lilly posts profit drop on charges, lifts outlook

Article Abstract:

First-quarter profits for pharmaceutical firm Eli Lilly and Co. fell 39% primarily due to lawsuit settlements and drug-pipeline obstructions; however, revenue increased by 14% for impotence and antipsychotic agents. The firm has raised its full-year outlook.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

Amgen's net income rises 20%; new drugs help Lilly post profit

Article Abstract:

Amgen Inc. of the United States posted strong earnings in the fourth quarter with net income increasing 20 percent to $824 million. Revenue is up 12 percent to $3.27 billion. Strong earnings are projected for 2006.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code: